Literature DB >> 20179792

The diagnosis and management of hereditary haemochromatosis.

Paul Clark1, Laurence J Britton, Lawrie W Powell.   

Abstract

Hereditary haemochromatosis (HH) is a common genetic disorder of iron metabolism in individuals of Northern European ancestry which leads to inappropriate iron absorption from the intestine and iron overload in susceptible individuals. Iron overload is suggested by elevations in serum ferritin and transferrin saturation. The majority of patients with clinically significant iron overload are homozygous for the C282Y mutation of the HFE gene, however only a minority of C282Y homozygotes fully express the disease clinically. Those with a high serum ferritin (>1000 microg/L) and additional hepatic insults from cofactors are more likely to develop cirrhosis and its complications. The mainstay of treatment is venesection. Those without cirrhosis who undergo appropriate venesection have a normal life expectancy. Family screening is recommended for all first degree relatives of an individual with the disease.

Entities:  

Year:  2010        PMID: 20179792      PMCID: PMC2826266     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN: 0159-8090


  39 in total

1.  Why there is discordance in reported decision thresholds for transferrin saturation when screening for hereditary hemochromatosis.

Authors:  M A McCullen; D H Crawford; G Dimeski; J Tate; P E Hickman
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

2.  Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation.

Authors:  K A Stuart; L M Fletcher; A D Clouston; S V Lynch; D M Purdie; P Kerlin; D H Crawford
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

3.  Reversible cardiac dysfunction in hemochromatosis.

Authors:  J Rivers; P Garrahy; W Robinson; A Murphy
Journal:  Am Heart J       Date:  1987-01       Impact factor: 4.749

4.  Psychosocial impact of C282Y mutation testing for hemochromatosis.

Authors:  T E Power; P C Adams
Journal:  Genet Test       Date:  2001

5.  Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis.

Authors:  C E McLaren; G J McLachlan; J W Halliday; S I Webb; B A Leggett; E C Jazwinska; D H Crawford; V R Gordeuk; G D McLaren; L W Powell
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

6.  A population-based study of the clinical expression of the hemochromatosis gene.

Authors:  J K Olynyk; D J Cullen; S Aquilia; E Rossi; L Summerville; L W Powell
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

7.  Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives.

Authors:  Maria Elmberg; Rolf Hultcrantz; Anders Ekbom; Lena Brandt; Sigvard Olsson; Rolf Olsson; Stefan Lindgren; Lars Lööf; Per Stål; Sven Wallerstedt; Sven Almer; Hanna Sandberg-Gertzén; Johan Askling
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

8.  Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis.

Authors:  Darrell H G Crawford; Linda M Fletcher; Stefan G Hubscher; Katherine A Stuart; Edward Gane; Peter W Angus; Gary P Jeffrey; Geoffrey W McCaughan; Paul Kerlin; Lawrie W Powell; Elwyn E Elias
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

Review 9.  Hereditary haemochromatosis.

Authors:  M C H Janssen; D W Swinkels
Journal:  Best Pract Res Clin Gastroenterol       Date:  2009       Impact factor: 3.043

10.  Long-term survival in patients with hereditary hemochromatosis.

Authors:  C Niederau; R Fischer; A Pürschel; W Stremmel; D Häussinger; G Strohmeyer
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  6 in total

1.  Fe²⁺ block and permeation of CaV3.1 (α1G) T-type calcium channels: candidate mechanism for non-transferrin-mediated Fe²⁺ influx.

Authors:  Kyle V Lopin; I Patrick Gray; Carlos A Obejero-Paz; Frank Thévenod; Stephen W Jones
Journal:  Mol Pharmacol       Date:  2012-09-12       Impact factor: 4.436

2.  Non-invasive methods for liver fibrosis prediction in hemochromatosis: One step beyond.

Authors:  Agustin Castiella; Eva Zapata; José M Alústiza
Journal:  World J Hepatol       Date:  2010-07-27

3.  Unusual presentation of hemochromatosis as isolated metacarpophalangeal joint osteoarthritis: a case report.

Authors:  Sunishka M Wimalawansa; Rannie Alsamkari
Journal:  Hand (N Y)       Date:  2011-05-03

4.  Iranian hereditary hemochromatosis patients: baseline characteristics, laboratory data and gene mutations.

Authors:  Farhad Zamani; Zohreh Bagheri; Maryam Bayat; Seyed-Mohammad Fereshtehnejad; Ali Basi; Hossein Najmabadi; Hossein Ajdarkosh
Journal:  Med Sci Monit       Date:  2012-10

5.  Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.

Authors:  Etheresia Pretorius; Janette Bester; Natasha Vermeulen; Boguslaw Lipinski; George S Gericke; Douglas B Kell
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

6.  Hemochromatosis risk genotype is not associated with colorectal cancer or age at its diagnosis.

Authors:  Gail P Jarvik; Xiaoliang Wang; Pierre Fontanillas; Esther Kim; Sirisak Chanprasert; Adam S Gordon; Lisa Bastarache; Kris V Kowdley; Tabitha Harrison; Elisabeth A Rosenthal; Ian B Stanaway; Stéphane Bézieau; Stephanie J Weinstein; Polly A Newcomb; Graham Casey; Elizabeth A Platz; Kala Visvanathan; Loic Le Marchand; Cornelia M Ulrich; Sheetal Hardikar; Christopher I Li; Franzel J B van Duijnhoven; Andrea Gsur; Peter T Campbell; Victor Moreno; Pavel Vodička; Hermann Brenner; Jenny Chang-Claude; Michael Hoffmeister; Martha L Slattery; Marc J Gunter; Elom K Aglago; Sergi Castellví-Bel; Sun-Seog Kweon; Andrew T Chan; Li Li; Wei Zheng; D Timothy Bishop; Graham G Giles; Gad Rennert; Kenneth Offit; Temitope O Keku; Michael O Woods; Jochen Hampe; Bethan Van Guelpen; Steven J Gallinger; Albert de la Chapelle; Heather Hampel; Sonja I Berndt; Catherine M Tangen; Annika Lindblom; Alicja Wolk; Andrea Burnett-Hartman; Anna H Wu; Emily White; Stephen B Gruber; Mark A Jenkins; Joanna Mountain; Ulrike Peters; David R Crosslin
Journal:  HGG Adv       Date:  2020-08-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.